NCT04528901Unknown不适用
Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)
University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 1,080 人开始时间: 2020年9月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,080
- 试验地点
- 1
- 主要终点
- Determine and compare the seroprevalence for SARS-CoV2 among patients with respiratory pathologies monitored in Pneumology at the Strasbourg University Hospital, in the cluster zone of the Grand Est.
研究概览
简要总结
seroPREvalence vis-à-vis SARS-CoV2 and correlation with clinical forms of COVID-19 in patients followed in Pulmonology in the cluster area of the Grand-Est region.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Man or woman from 18 years old and without upper age limit
- •Patient followed in pulmonology at Strasbourg University Hospital
- •Patient presenting at least one of the following pathologies:
- •severe persistent asthma (200 patients)
- •chest cancer that is active or has received treatment within a period of less than one year (300 patients)
- •history of lung transplantation performed before the start of the epidemic (02/29/2020) (300 patients)
- •idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis (70 patients)
- •pulmonary arterial hypertension (PAH) (group 1 of the international classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)
- •Severe COPD in the respiratory failure stage (150 patients)
- •Subject affiliated to a social health insurance protection scheme
- •Subject able to understand the objectives of the research
- •Subject having signed an informed consent
排除标准
- •Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
- •Subject under safeguard of justice
- •Subject under guardianship or guardianship
结局指标
主要结局
Determine and compare the seroprevalence for SARS-CoV2 among patients with respiratory pathologies monitored in Pneumology at the Strasbourg University Hospital, in the cluster zone of the Grand Est.
时间窗: 15 months
Carrying out a serological assay of specific antibodies to SARS-CoV-2
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive DrugsChronic Inflammatory RheumatismNCT04530682University Hospital, Montpellier163
已完成
不适用
Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for SurgeryCovid19SurgerySARS (Severe Acute Respiratory Syndrome)NCT04480580University of Cagliari100
已完成
不适用
Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWsCovid19NCT04563247Lahore General Hospital970
招募中
不适用
Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in LeipzigU07.1COVID-19, virus identifiedDRKS00023364Institut für Medizinische Mikrobiologie und Virologie, Universitätsklinikum Leipzig2,000
已完成
不适用
Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss populatioISRCTN18181860Swiss School of Public Health28,000